Prediction of immunochemotherapy response for diffuse large B‐cell lymphoma using artificial intelligence digital pathology

Prediction of immunochemotherapy response for diffuse large B‐cell lymphoma using artificial intelligence digital pathology

Abstract Diffuse large B‐cell lymphoma (DLBCL) is a heterogeneous and prevalent subtype of aggressive non‐Hodgkin lymphoma that poses diagnostic and prognostic challenges, particularly in predicting drug responsiveness. In this study, we used digital pathology and deep learning to predict responses...

Full description

Bibliographic Details
Main Authors: Jeong Hoon Lee, Ga‐Young Song, Jonghyun Lee, Sae‐Ryung Kang, Kyoung Min Moon, Yoo‐Duk Choi, Jeanne Shen, Myung‐Giun Noh, Deok‐Hwan Yang
Format: Article
Language:English
Published: Wiley 2024-05-01
Series:The Journal of Pathology: Clinical Research
Subjects:
diffuse large B‐cell lymphoma (DLBCL)
digital pathology
deep learning
multi‐modal prediction model
Online Access:https://doi.org/10.1002/2056-4538.12370

Internet

https://doi.org/10.1002/2056-4538.12370

Similar Items